Skip to main content
Christopher Oermann, MD, Pediatric Pulmonology, Kansas City, MO, Children's Mercy Kansas City

ChristopherMichaelOermannMD

Pediatric Pulmonology Kansas City, MO

Cystic Fibrosis Pulmonology, Pediatric Asthma Pulmonology, Pediatric Interstitial Lung Disease Pulmonology

Division Director, Pulmonary and Sleep Medicine Children's Mercy - Kansas City

Dr. Oermann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Oermann's full profile

Already have an account?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Pulmonology, 1994 - 1997
  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Pediatrics, 1989 - 1993
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1989

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2013 - 2025
  • KS State Medical License
    KS State Medical License 2013 - 2024
  • TX State Medical License
    TX State Medical License 1997 - 2015
  • American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FAAP) American Academy of Pediatrics

Publications & Presentations

PubMed

Other

Press Mentions

  • A Popular Asthma Inhaler Will Be Discontinued in January. Here's What To Know.
    A Popular Asthma Inhaler Will Be Discontinued in January. Here's What To Know.January 4th, 2024
  • Experts Call on Insurers to Prioritize Corticosteroid Medicines Appropriate for Children
    Experts Call on Insurers to Prioritize Corticosteroid Medicines Appropriate for ChildrenDecember 13th, 2023
  • Asthma Inhaler to Be Discontinued in January – Here's What Patients Should Know
    Asthma Inhaler to Be Discontinued in January – Here's What Patients Should KnowJanuary 2nd, 2024

Grant Support

  • A Phase 2, Randomized, Double Blind, Parallel Dose Ranging Study Of Oral TherNational Center For Research Resources2006
  • Study Of Oral Theraclec-Total In Cystic Fibrosis Subjects W/ Pancreatic InsuffNational Center For Research Resources2005
  • Ascending Doses Of Aztreonam (INHALATION) In Cystic FibrNational Center For Research Resources2004

Professional Memberships

Hospital Affiliations